Affiliation:
1. Islamic Azad University Tehran North Branch
2. Shahid Beheshti University of Medical Sciences Research Institute for Gastroenterology and Liver Diseases
3. Gonabad University of Medical Sciences
4. Guilan University of Medical Sciences
Abstract
Abstract
Toxoplasma gondii is a protozoan parasite that infects more than a third of the world's population. The drugs used today to treat toxoplasmosis cause severe side effects in many people and have poor success in treating chronic infections. In the current study, extracted oil from tea leaf was loaded into solid lipid nanoparticles (SLNs) and its anti-Toxoplasma properties were analyzed. Double emulsification technique was employed to provide SLNs and its physical criteria was calculated by transmission electron microscope (TEM) and dynamic light scattering (DLS). Cell toxicity and anti-intracellular Toxoplasma activity were investigated by a MTT assay. The anti-Toxoplasma activity of TTO-SLNs was evaluated by trypan-blue staining. The TTO-SLNs were round with a mean particle size of 85.23 nm and clear and stable margins. An association was seen between the cell toxicity of TTO-SLNs with the concentration of the component (P-value = 0.009). The cytotoxic concentration (CC50) against Toxoplasma was > 10 mg/mL, while it was concentration-dependent (P-value < 0.0001). the viability of T. gondii- infected Vero cells was higher in lower concentrations of TTO-SLNs (P-value = 0.0174), while at least 80% of T. gondii- infected Vero cells remained alive in the concentration ˃1 mg/mL. Overall, our findings demonstrated high anti-T. gondii properties of TTO-SLNs, suggesting the promising role of SLNs to carry TTO. In addition, our findings showed prolonged release of the TTO from SLNs capsulation of the can lead to, suggesting the capability of TTO-SLNs to be employed for chronic phase (cyst stages), which should be further investigated in animal models.
Publisher
Research Square Platform LLC
Reference88 articles.
1. Toxoplasmosis in immunocompromised patients in Iran: a systematic review and meta-analysis;Ahmadpour E;J Infect Dev Ctries,2014
2. The molecular basis of sulfonamide resistance in Toxoplasma gondii and implications for the clinical management of toxoplasmosis;Aspinall TV;J Infect Dis,2002
3. In vitro activity of Melaleuca alternifolia (tea tree) oil against bacterial and Candida spp. isolates from clinical specimens;Banes-Marshall L;Br J Biomed Sci,2001
4. Adverse event profile of pyrimethamine-based therapy in toxoplasmosis: a systematic review;Ben-Harari RR;Drugs R D,2017
5. Béraud G, Pierre-François S, Foltzer A, Abel S, Liautaud B, Smadja D, Cabié A (2009)